In addition, our findings demonstrated that FOXN3 over-expression triggered an obvious reduction in PCNA, CCND1, MMP9 and Vimentin expression levels in glioma cells, whereas FOXN3 ablation elicited a remarkable elevation in PCNA, CCND1, MMP9 and Vimentin expression levels. Here, FOXN3 is linked to central nervous system cancer.